News
1
Most adults in America wear some form of vision correction. However, the majority of people are in the dark when it comes to making eyewear and eye care decisions, including choosing frames, lenses, and knowing how to effectively maximize their...
2
Polypharmacy is the concurrent use of multiple drugs (usually 5+) to treat multiple diseases and health conditions. It can often lead to safety concerns, particularly with older adults. Multiple medications can be difficult to manage and keep track of,...
3
The past couple of weeks have seen incredible changes for all of us—from business practices to the way we live our lives. As we brace ourselves for several more weeks of social distancing and uncertainty it’s important to take a moment to...
4
A recent study1 links uncorrected vision loss to an increased risk of death among seniors. While the study couldn’t provide a definitive reason for the connection, the researchers involved do have a theory.
Researchers speculate the cause for...
5
Check out our new member resource hub where you can find all recent Benefactor articles as well as additional resources on topics such as vision benefits, prescription benefits, human resources, and mindfulness!
Enter Hub
6
Clinical reviews are essential in administering an employer-sponsored prescription benefit program. All prescription benefit managers (PBMs) have some form of clinical review in place for their clients, and these programs are typically vetted through a...
7
Feature in Benefits MagazineBenecard President, Dave Karlin, was featured in the October 2020 issue of Benefits Magazine. In the article, he discusses how the added benefit of mindfulness has helped Benecard employees through the COVID-19...
8
As an exceptional amount of people are making the decision to switch jobs in 2021, voluntary benefits have become more and more important for employers to offer.
The “Great Resignation”
In the fallout of the coronavirus pandemic, we are...
9
Gilead Sciences’ Hepatitis C Virus (HCV) Treatment Drug Sovaldi came as a medical breakthrough with a 90% cure rate. However, this medical breakthrough comes with an eye popping price tag in the U.S. with no price break in sight. If...
10
Agency Warns Eight Companies Regarding Their Unapproved Ophthalmic Drugs
Press release originally posted on www.fda.gov
The U.S. Food and Drug Administration has issued warning letters to eight companies for manufacturing or marketing unapproved...